Chemists Design Bifunctional Fluoroalkylation Reagent

A new chemical reagent enables simultaneous fluoroalkylation and azide click handle attachment to molecules.

Updated on Oct. 16, 2026 in Chemistry

Bold flat-color editorial illustration featuring a geometric chemistry flask containing a molecular structure, representing scientific innovation.
Researchers at the Czech Academy of Sciences have developed a bifunctional reagent that streamlines complex chemical modifications for pharmaceutical and research applications. AI Illustration. Upload story photo >

Researchers at the Czech Academy of Sciences have developed a new reagent that simplifies chemical synthesis by performing two distinct modifications at once. This tool allows for the efficient attachment of fluoroalkyl fragments and azide click handles to various compounds.

Why it matters

The reagent offers a more accessible way to add groups that can improve a drug's metabolic stability and bioavailability. By combining functionalities, it potentially streamlines the creation of complex molecular structures for research.

The reagent, sodium 2-azido-1,1,2,2-tetrafluoroethanesulfinate, is synthesized in a single step using three feedstocks: tetrafluoroethylene, sodium azide, and sulfur dioxide. It facilitates radical addition and click chemistry on arenes, heteroarenes, thiols, and alkenes.

The players

Czech Academy of Sciences

This is a public research institution in the Czech Republic that serves as the central hub for the design of the new chemical reagent.

Trastuzumab

This monoclonal antibody is an FDA-approved drug used in clinical oncology to treat patients with HER2-positive breast and stomach cancers.

Phil Baran

He is a prominent chemist at Scripps Research who previously led a research group in reporting a bifunctional reagent in 2013.

The details

The team demonstrated the versatility of this reagent by successfully attaching a coumarin-based fluorescent probe to the monoclonal antibody trastuzumab, which is used to treat breast and stomach cancers. This bifunctional approach aims to simplify structural modifications that were previously more cumbersome to perform.

Timeline

  1. 2013: Phil Baran's group reported an earlier bifunctional reagent.

  2. 2026-10-16

    The new reagent design was formally reported.

The Big Picture

This development follows the pattern set by the 2013 Phil Baran group report in the evolution of bifunctional chemical tools. It shifts the discipline toward using more accessible feedstocks to achieve complex radical additions and click chemistry in a single step.

This chemical advancement could lead to more efficient and stable drug delivery systems for cancer treatments like trastuzumab. By improving metabolic stability and membrane permeability, such modifications potentially enhance the efficacy of future pharmaceutical compounds.

The takeaway

This development highlights the ongoing effort in medicinal chemistry to simplify the complex process of drug modification. Researchers can now utilize a more accessible reagent to potentially enhance the therapeutic performance of life-saving antibodies.

What happens next

The research team plans to conduct further exploration into using this reagent for peptide or DNA derivatization. Additionally, future work aims to develop new conditions to generate the necessary free radicals using visible light.

Further reading

For more on the latest research in molecular synthesis, explore our dedicated Chemistry section.

Source note: This article includes information reported by Chemistry World.